Literature DB >> 18286306

Renal cell carcinoma in a patient with cystinosis and inflammatory bowel disease: a case report.

Cheryl Cameron1, Larry Greenbaum, Thomas Sato, Beth Trost, Brian Lundeen, Michael E Kelly.   

Abstract

An 18-year-old male patient with a history of cystinosis and inflammatory bowel disease, who was being treated with cysteamine and 6-mercaptopurine, had an incidental finding of a mass in the right kidney on a renal ultrasound to evaluate worsening renal insufficiency. Excisional biopsy demonstrated papillary renal cell carcinoma, Type 2. Renal cell carcinoma is typically a disease of older adults, and it is not known to be associated with cystinosis. This is the first published report of renal cell carcinoma in a patient with cystinosis.

Entities:  

Mesh：

Year:  2008        PMID： 18286306     DOI： 10.1007/s00467-008-0773-6

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


  14 in total

Review 1.  First NIH/Office of Rare Diseases Conference on Cystinosis: past, present, and future.

Authors:  Robert Kleta; Frederick Kaskel; Ranjan Dohil; Paul Goodyer; Lisa M Guay-Woodford; Erik Harms; Julie R Ingelfinger; Vera H Koch; Craig B Langman; Mary B Leonard; Roslyn B Mannon; Minnie Sarwal; Jerry A Schneider; Flemming Skovby; Barbara C Sonies; Jess G Thoene; Doris A Trauner; William A Gahl
Journal:  Pediatr Nephrol       Date:  2005-01-27       Impact factor: 3.714

Review 2.  Renal-cell carcinoma.

Authors:  Herbert T Cohen; Francis J McGovern
Journal:  N Engl J Med       Date:  2005-12-08       Impact factor: 91.245

Review 3.  The risk of lymphoma in the treatment of inflammatory bowel disease with immunosuppressive agents.

Authors:  John H Kwon; Richard J Farrell
Journal:  Crit Rev Oncol Hematol       Date:  2005-10       Impact factor: 6.312

4.  Meta-analysis of risk of malignancy with immunosuppressive drugs in inflammatory bowel disease.

Authors:  Yukari Masunaga; Keiko Ohno; Ryuichi Ogawa; Masayuki Hashiguchi; Hirotoshi Echizen; Hiroyasu Ogata
Journal:  Ann Pharmacother       Date:  2007-01-02       Impact factor: 3.154

5.  Inflammatory bowel disease in a patient with nephropathic cystinosis.

Authors:  W R Treem; E J Rusnack; B D Ragsdale; M G Seikaly; J S DiPalma
Journal:  Pediatrics       Date:  1988-04       Impact factor: 7.124

6.  Renal cell carcinoma: prognostic significance of incidentally detected tumors.

Authors:  K H Tsui; O Shvarts; R B Smith; R Figlin; J B de Kernion; A Belldegrun
Journal:  J Urol       Date:  2000-02       Impact factor: 7.450

7.  Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine.

Authors:  A G Fraser; T R Orchard; E M Robinson; D P Jewell
Journal:  Aliment Pharmacol Ther       Date:  2002-07       Impact factor: 8.171

8.  Ulcerative colitis complicated by renal cell carcinoma: a series of three patients.

Authors:  J Satsangi; J Marshall; D Roskell; D Jewell
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

9.  Rapid inactivation of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX), a potent mutagen in chlorinated drinking water, by sulfhydryl compounds.

Authors:  M Watanabe; H Kobayashi; T Ohta
Journal:  Mutat Res       Date:  1994-04       Impact factor: 2.433

10.  Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma.

Authors:  Stephen D W Beck; Manish I Patel; Mark E Snyder; Michael W Kattan; Robert J Motzer; Victor E Reuter; Paul Russo
Journal:  Ann Surg Oncol       Date:  2004-01       Impact factor: 5.344
View more
  3 in total

1.  Long-term outcome of nephropathic cystinosis: a 20-year single-center experience.

Authors:  Marcella Greco; Milena Brugnara; Marco Zaffanello; Anna Taranta; Anna Pastore; Francesco Emma
Journal:  Pediatr Nephrol       Date:  2010-08-29       Impact factor: 3.714

Review 2.  Adult complications of nephropathic cystinosis: a systematic review.

Authors:  Rachel Nora Kasimer; Craig B Langman
Journal:  Pediatr Nephrol       Date:  2020-02-03       Impact factor: 3.714

3.  Better survival of renal cell carcinoma in patients with inflammatory bowel disease.

Authors:  Lauranne A A P Derikx; Loes H C Nissen; Joost P H Drenth; Carla M van Herpen; Wietske Kievit; Rob H A Verhoeven; Peter F A Mulders; Christina A Hulsbergen-van de Kaa; Marye J Boers-Sonderen; Tim R A van den Heuvel; Marieke Pierik; Iris D Nagtegaal; Frank Hoentjen
Journal:  Oncotarget       Date:  2015-11-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.